Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Newleos Therapeutics is pioneering next-generation therapies for mental health conditions, focusing on anxiety and substance use disorders—two major areas of unmet medical need. Our clinical-stage pipeline, licensed from Roche, includes oral small molecules targeting GABAA-γ1, V1a, TAAR1, and GABAA-α5, with broad potential in anxiety, substance use, and cognitive impairment. Co-founded by Longwood Fund, Dr. Federico Bologn...
    Newleos Therapeutics is pioneering next-generation therapies for mental health conditions, focusing on anxiety and substance use disorders—two major areas of unmet medical need. Our clinical-stage pipeline, licensed from Roche, includes oral small molecules targeting GABAA-γ1, V1a, TAAR1, and GABAA-α5, with broad potential in anxiety, substance use, and cognitive impairment. Co-founded by Longwood Fund, Dr. Federico Bolognani, and Dr. William Martin, Newleos is dedicated to delivering first- and best-in-class treatments for neuropsychiatric disorders.

    List your booth number for exhibitions, ask us